|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 2011-02-28 |
| Corporate Officer/Principal | - | 2011-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 2011-02-28 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.63% | +2.92% | +20.84% | -7.74% | 66.56B | ||
| -1.97% | -3.45% | +49.74% | +221.13% | 56.51B | ||
| -1.13% | +40.50% | +40.50% | +40.50% | 42.98B | ||
| +1.99% | +8.15% | -48.83% | -54.69% | 40.46B | ||
| -1.93% | -1.97% | +63.19% | -25.49% | 31.91B | ||
| +3.64% | +17.16% | +173.11% | -30.97% | 31.65B | ||
| -1.20% | +0.72% | +71.67% | +83.71% | 23.35B | ||
| +3.08% | +20.43% | +4.99% | +186.85% | 19.46B | ||
| +0.21% | +3.76% | +67.83% | +133.69% | 17.18B | ||
| Average | +0.21% | +9.08% | +49.23% | +60.78% | 36.67B | |
| Weighted average by Cap. | -0.11% | +7.69% | +43.61% | +53.33% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
















